Drug intelligence / Profile preview

magnesium + artificial cerebrospinal fluid

Development stage
Unknown
Lead developer
Fuso Pharmaceutical Industries
Modality
Small Molecules
Administration
Intracisternal, Intraventricular
01

Overview

Magnesium + artificial cerebrospinal fluid (Mg-aCSF) is a neuroprotective irrigation solution designed to mimic the physiological and electrolyte balance of natural cerebrospinal fluid while providing therapeutic concentrations of magnesium ions. Primarily utilized in neurosurgical procedures, particularly following subarachnoid hemorrhage (SAH), the solution is administered via intracisternal or intraventricular irrigation. Its primary mechanism of action is mediated by magnesium's role as a voltage-dependent, non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor, which prevents calcium-induced excitotoxicity in neurons. Additionally, magnesium acts as a natural calcium channel blocker in vascular smooth muscle, promoting vasodilation of cerebral arteries to prevent or mitigate delayed cerebral ischemia and vasospasm. The balanced electrolyte environment of the artificial cerebrospinal fluid carrier helps maintain osmotic and ionic stability in the central nervous system during therapy.

Other names
magnesium-containing artificial cerebrospinal fluidmagnesium-enriched artificial cerebrospinal fluidmagnesium sulfate in artificial cerebrospinal fluid
02

Targets

CaV (Voltage-gated calcium channel protein complex)NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on magnesium + artificial cerebrospinal fluid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on magnesium + artificial cerebrospinal fluid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call